HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.
Research HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. (600566.SS) on Bullrun: market cap CNY 27.20B, P/E 15.0, dividend yield 5.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker600566.SS
- ExchangeSS
- CountryChina
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyCNY
- Market capCNY 27.20B
- P/E15.0
- Dividend yield5.9%
- Financial periodQ2 2026
- RevenueCNY 1.12B
- Net incomeCNY 384.08M
- Free cash flow-CNY 52.90M
- Gross margin76.6%
Valuation Snapshot
latest market cap is CNY 27.20B; P/E is 15.0; dividend yield is 5.9%.
Peer valuation comparison
Latest P/E is 14.97x versus a Healthcare sector median of 21.8x (31.3% below).
Latest dividend yield is 5.9% versus a Healthcare sector median of 2.4% (145.8% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-11-11 | CNY 27.20B | 15.0 | 5.8% | 1.74 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.74 CNY, yield 5.9%.
About HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.
Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of medicines in China. The company offers drugs in the fields of pediatrics, respiratory system, digestive system, and gynecology. It is also involved in daily chemical product sales; and wholesale and retail pharmaceuticals. The company is headquartered in Taixing, China.
ETFs that hold HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.
US-listed ETFs
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. is held by 16 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | <0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Vanguard FTSE All-World ex-US Index Fund ETF Shares (VEU) | <0.01% | 0.04% |
| Schwab Emerging Markets Equity ETF (SCHE) | <0.01% | 0.06% |
| Vanguard International High Dividend Yield Index Fund ETF Shares (VYMI) | <0.01% | 0.07% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.'s market cap?
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.'s market capitalization is CNY 27.20B.
What is HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.'s P/E ratio?
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.'s price-to-earnings (P/E) ratio is 15.0.
Does HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. pay a dividend?
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. has a dividend yield of 5.9%.
What does HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. do?
Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of medicines in China. The company offers drugs in the fields of pediatrics, respiratory system, digestive system, and gynecology. It is also involved in daily chemical product sales; and wholesale and retail pharmaceuticals. The company is headquartered in Taixing, China.